Kellen Scott 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 26, 2019
Insider Transaction Report
Form 4
Kellen Scott
CFO & Secretary
Transactions
- Award
Stock Option (right to buy)
2019-06-24+99,750→ 99,750 totalExercise: $4.60Exp: 2029-06-23→ Common Shares (99,750 underlying)
Holdings
- 7,290
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]Vests in eight nearly equal quarterly installments over two years.